questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Globulines
Sérum-globulines
Immunoglobulines
Paraprotéines
Paraprotéines : Questions médicales fréquentes
Diagnostic
5
Protéines monoclonales
Myélome multiple
Électrophorèse
Immunofixation
Imagerie médicale
Lésions osseuses
Symptômes
5
Infections
Système immunitaire
Néphropathie
Problèmes rénaux
Neuropathie
Engourdissements
Prévention
5
Facteurs de risque
Obésité
Bilan de santé
Détection précoce
Alimentation
Santé générale
Traitements
5
Chimiothérapie
Radiothérapie
Transplantation de moelle osseuse
Myélome multiple
Médicaments immunomodulateurs
Système immunitaire
Corticostéroïdes
Inflammation
Médecine personnalisée
Réponse au traitement
Complications
5
Lésions osseuses
Infections
Troubles sanguins
Coagulation
Qualité de vie
Douleur chronique
Gestion des complications
Permanence
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Expositions environnementales
Radiations
Maladies auto-immunes
Lupus
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Paraprotéines : Questions médicales les plus fréquentes",
"headline": "Paraprotéines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Paraprotéines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-20",
"dateModified": "2026-09-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Paraprotéines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Immunoglobulines",
"url": "https://questionsmedicales.fr/mesh/D007136",
"about": {
"@type": "MedicalCondition",
"name": "Immunoglobulines",
"code": {
"@type": "MedicalCode",
"code": "D007136",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine de Bence Jones",
"alternateName": "Bence Jones Protein",
"url": "https://questionsmedicales.fr/mesh/D001536",
"about": {
"@type": "MedicalCondition",
"name": "Protéine de Bence Jones",
"code": {
"@type": "MedicalCode",
"code": "D001536",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.900.120"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cryoglobulines",
"alternateName": "Cryoglobulins",
"url": "https://questionsmedicales.fr/mesh/D003450",
"about": {
"@type": "MedicalCondition",
"name": "Cryoglobulines",
"code": {
"@type": "MedicalCode",
"code": "D003450",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.900.225"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pyroglobulines",
"alternateName": "Pyroglobulins",
"url": "https://questionsmedicales.fr/mesh/D011750",
"about": {
"@type": "MedicalCondition",
"name": "Pyroglobulines",
"code": {
"@type": "MedicalCode",
"code": "D011750",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.900.700"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Paraprotéines",
"alternateName": "Paraproteins",
"code": {
"@type": "MedicalCode",
"code": "D010266",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jillian R Tate",
"url": "https://questionsmedicales.fr/author/Jillian%20R%20Tate",
"affiliation": {
"@type": "Organization",
"name": "Chemical Pathology, Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, Qld 4029, Australia."
}
},
{
"@type": "Person",
"name": "Michael P Lunn",
"url": "https://questionsmedicales.fr/author/Michael%20P%20Lunn",
"affiliation": {
"@type": "Organization",
"name": "National Hospital for Neurology and Neurosurgery, Centre for Neuromuscular Disease, Queen Square, London, England."
}
},
{
"@type": "Person",
"name": "Nilika Wijeratne",
"url": "https://questionsmedicales.fr/author/Nilika%20Wijeratne",
"affiliation": {
"@type": "Organization",
"name": "Chemical Pathology, Dorevitch Pathology, Heidelberg, Vic. 3084, Australia."
}
},
{
"@type": "Person",
"name": "Louise Wienholt",
"url": "https://questionsmedicales.fr/author/Louise%20Wienholt",
"affiliation": {
"@type": "Organization",
"name": "The Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP), St Leonards, NSW 2065, Australia."
}
},
{
"@type": "Person",
"name": "Peter Mollee",
"url": "https://questionsmedicales.fr/author/Peter%20Mollee",
"affiliation": {
"@type": "Organization",
"name": "Haematology Department, Princess Alexandra Hospital, Brisbane, Qld 4102, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Neuropathies and paraproteins.",
"datePublished": "2019-10-00",
"url": "https://questionsmedicales.fr/article/31313705",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/WCO.0000000000000726"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Paraproteins. A review].",
"datePublished": "2019-Aug-00",
"url": "https://questionsmedicales.fr/article/31859969",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4067/S0034-98872019000801036"
}
},
{
"@type": "ScholarlyArticle",
"name": "Paraprotein-Mediated Glomerular Diseases.",
"datePublished": "2024-Jul-00",
"url": "https://questionsmedicales.fr/article/39084761",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.akdh.2024.02.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "False Decrease in Uric Acid Caused by IgM Paraprotein.",
"datePublished": "2023-Oct-01",
"url": "https://questionsmedicales.fr/article/37844058",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7754/Clin.Lab.2023.230508"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Paraprotein-related kidney disease. Experience in 22 cases].",
"datePublished": "2020-Aug-00",
"url": "https://questionsmedicales.fr/article/33399771",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4067/S0034-98872020000801059"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Globulines",
"item": "https://questionsmedicales.fr/mesh/D005916"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sérum-globulines",
"item": "https://questionsmedicales.fr/mesh/D012712"
},
{
"@type": "ListItem",
"position": 6,
"name": "Immunoglobulines",
"item": "https://questionsmedicales.fr/mesh/D007136"
},
{
"@type": "ListItem",
"position": 7,
"name": "Paraprotéines",
"item": "https://questionsmedicales.fr/mesh/D010266"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Paraprotéines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Paraprotéines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Paraprotéines",
"description": "Comment diagnostiquer une paraprotéine ?\nQuels examens sont utilisés pour le diagnostic ?\nQuels symptômes indiquent une paraprotéine ?\nQuel rôle joue la biopsie dans le diagnostic ?\nLes tests d'imagerie sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D010266#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Paraprotéines",
"description": "Quels sont les symptômes courants des paraprotéines ?\nLes paraprotéines causent-elles des infections ?\nComment les paraprotéines affectent-elles les reins ?\nY a-t-il des symptômes neurologiques associés ?\nLes paraprotéines peuvent-elles causer des saignements ?",
"url": "https://questionsmedicales.fr/mesh/D010266#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Paraprotéines",
"description": "Peut-on prévenir les paraprotéines ?\nQuels facteurs de risque sont associés ?\nLes examens réguliers sont-ils recommandés ?\nL'alimentation joue-t-elle un rôle préventif ?\nLe tabagisme influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D010266#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Paraprotéines",
"description": "Quels traitements sont disponibles pour les paraprotéines ?\nLa transplantation de moelle osseuse est-elle une option ?\nLes médicaments immunomodulateurs sont-ils efficaces ?\nQuel est le rôle des corticostéroïdes dans le traitement ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D010266#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Paraprotéines",
"description": "Quelles complications peuvent survenir avec les paraprotéines ?\nLes paraprotéines peuvent-elles causer des troubles sanguins ?\nY a-t-il un risque de cancer associé ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D010266#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Paraprotéines",
"description": "Quels sont les principaux facteurs de risque ?\nLe mode de vie influence-t-il le risque ?\nLes expositions environnementales sont-elles un facteur ?\nLes maladies auto-immunes sont-elles liées ?\nL'origine ethnique joue-t-elle un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D010266#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une paraprotéine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test sanguin pour détecter les protéines monoclonales est essentiel."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'électrophorèse des protéines et la immunofixation sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une paraprotéine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, douleurs osseuses et infections fréquentes peuvent signaler une paraprotéine."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la biopsie dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie de la moelle osseuse aide à confirmer la présence de plasmocytes anormaux."
}
},
{
"@type": "Question",
"name": "Les tests d'imagerie sont-ils nécessaires ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les radiographies ou IRM peuvent détecter des lésions osseuses associées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des paraprotéines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleurs osseuses, et anémie."
}
},
{
"@type": "Question",
"name": "Les paraprotéines causent-elles des infections ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent affaiblir le système immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Comment les paraprotéines affectent-elles les reins ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer une néphropathie, entraînant des problèmes rénaux."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme des engourdissements ou des douleurs neuropathiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les paraprotéines peuvent-elles causer des saignements ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent affecter la coagulation, entraînant des saignements anormaux."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les paraprotéines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique pour les paraprotéines."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, l'obésité et des antécédents familiaux augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans de santé réguliers peuvent aider à détecter des anomalies précocement."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle préventif ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé générale, mais ne prévient pas directement."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque pour plusieurs cancers, y compris le myélome."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les paraprotéines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chimiothérapie, la radiothérapie et les thérapies ciblées."
}
},
{
"@type": "Question",
"name": "La transplantation de moelle osseuse est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être envisagée pour les cas avancés de myélome multiple."
}
},
{
"@type": "Question",
"name": "Les médicaments immunomodulateurs sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à réguler le système immunitaire et à réduire les paraprotéines."
}
},
{
"@type": "Question",
"name": "Quel est le rôle des corticostéroïdes dans le traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour réduire l'inflammation et contrôler les symptômes."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement est souvent adapté en fonction de la réponse du patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les paraprotéines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions osseuses, des infections et des problèmes rénaux."
}
},
{
"@type": "Question",
"name": "Les paraprotéines peuvent-elles causer des troubles sanguins ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des troubles de la coagulation et des anémies."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de cancer associé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les paraprotéines sont souvent liées à des cancers comme le myélome multiple."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent réduire la qualité de vie en provoquant douleur et fatigue chroniques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le sexe masculin et des antécédents familiaux de maladies plasmocytaires sont des risques."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme et l'obésité augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les expositions environnementales sont-elles un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines expositions chimiques et radiations peuvent augmenter le risque de myélome."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles liées ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le lupus peuvent augmenter le risque de paraprotéines."
}
},
{
"@type": "Question",
"name": "L'origine ethnique joue-t-elle un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines ethnies, comme les Afro-Américains, ont un risque plus élevé."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 06/09/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Chemical Pathology, Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, Qld 4029, Australia.
Publications dans "Paraprotéines" :
2 publications dans cette catégorie
Affiliations :
National Hospital for Neurology and Neurosurgery, Centre for Neuromuscular Disease, Queen Square, London, England.
Publications dans "Paraprotéines" :
2 publications dans cette catégorie
Affiliations :
Chemical Pathology, Dorevitch Pathology, Heidelberg, Vic. 3084, Australia.
Monash Pathology, Monash Health, Clayton, Vic. 3168, Australia.
Department of Medicine, Monash University, Clayton, Vic. 3168, Australia.
Publications dans "Paraprotéines" :
2 publications dans cette catégorie
Affiliations :
The Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP), St Leonards, NSW 2065, Australia.
Publications dans "Paraprotéines" :
2 publications dans cette catégorie
Affiliations :
Haematology Department, Princess Alexandra Hospital, Brisbane, Qld 4102, Australia.
School of Medicine, University of Queensland, Brisbane, Qld 4102, Australia.
Publications dans "Paraprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, James Paget University Hospital, Great Yarmouth, UK.
Publications dans "Paraprotéines" :
2 publications dans cette catégorie
Affiliations :
Drs. Tribedi Roy Diagnostic Laboratory, Kolkata, India.
Publications dans "Paraprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA.
Publications dans "Paraprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA.
Publications dans "Paraprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA.
Publications dans "Paraprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA.
Publications dans "Paraprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA.
Publications dans "Paraprotéines" :
1 publication dans cette catégorie
Affiliations :
Clinical Chemistry, HUSLAB Laboratory Services, HUS Diagnostics Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Publications dans "Paraprotéines" :
1 publication dans cette catégorie
Affiliations :
Metropolia University of Applied Sciences, Helsinki, Finland.
Publications dans "Paraprotéines" :
1 publication dans cette catégorie
Affiliations :
Clinical Chemistry, HUSLAB Laboratory Services, HUS Diagnostics Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Publications dans "Paraprotéines" :
1 publication dans cette catégorie
Affiliations :
Clinical Chemistry, HUSLAB Laboratory Services, HUS Diagnostics Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Publications dans "Paraprotéines" :
1 publication dans cette catégorie
Affiliations :
Sección Hematología, Hospital del Salvador, Santiago, Chile.
Publications dans "Paraprotéines" :
1 publication dans cette catégorie
Affiliations :
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
Publications dans "Paraprotéines" :
1 publication dans cette catégorie
Affiliations :
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
Publications dans "Paraprotéines" :
1 publication dans cette catégorie
Affiliations :
Department of Medicine, Section of Nephrology, University of Chicago, Chicago, IL.
Publications dans "Paraprotéines" :
There is an increasingly recognized association between haematological and neurological disease. This is especially true in the peripheral nervous system in which, to an extent, proof of a link is eas...
Our opportunities for treating these patients are greater not only through better recognition of disease but also treatments introduced from haematological research. Beyond rituximab, combination ther...
This review of the current literature focuses not only on the long-term outcome studies in anti-myelin-associated glycoprotein neuropathy, but developments in the diagnosis and treatment of monoclonal...
Hematological neoplasms are tumors of cells in different states of maturation and differentiation. Since monoclonal gammopathies (MG) refer to B mature lymphocyte neoplasms, lymphogenesis should be we...
Paraproteinemias are a group of complex diseases associated with an overproduction of a monoclonal immunoglobulin that can cause a diversity of kidney disorders and end-organ damage. In this review, w...
To explore the reason and treating method for the negative value of uric acid in a patient patient....
The serum of a patient with a negative uric acid detection value was diluted 5 times with "sterilized water" and with "normal saline". Additionally, the serum was treated with PEG6000 protein, and uri...
Elevated IgM paraprotein in the patient resulted in abnormal uric acid response curves in serum samples or diluted serum samples. After the serum was precipitated with PEG600, the uric acid response c...
The negative value of the patient's uric acid test was caused by the IgM paraprotein. After removing the interference by PEG6000 protein a true and accurate uric acid result was obtained....
One of the devastating consequences of monoclonal gammopathies is the development of end-stage kidney disease, which can be prevented with an early diagnosis. Renal involvement can be secondary to sat...
To report a retrospective analysis of patients who underwent a renal biopsy and whose final diagnosis was a form of monoclonal gammopathy....
We reviewed the clinical and laboratory features and response to treatment of 22 patients aged 63 ± 12 years (55% women) with a pathological diagnosis of a nephropathy associated with paraproteinemia....
The most common hematological diagnosis was amyloidosis in 50% of patients, followed by cast nephropathy. The predominant clinical presentations were proteinuria (without nephrotic syndrome) and nephr...
In this group of patients, light chains tend to affect the kidney more commonly than heavy chains. The prognosis of multiple myeloma is much worse than MGRS....
A 67 years old woman with a Waldenström disease was admitted in the intensive care unit for dyspnea and fever. During hospitalization, episodes of undetectable glycemia were observed without any hypog...
In June 2018, 77-year-old man was referred to The Department of Haematooncology, University Hospital Ostrava, for suspicion of multiple myeloma. This was supported by laboratory findings of hypercalce...
POEMS syndrome is a rare monoclonal plasma cell disease. The diagnosis of POEMS requires polyradiculoneuropathy and monoclonal plasma proliferating as 2 mandatory criteria, at least 1 of the major cri...
A 45-year-old woman complained of lower extremity edema, shortness of breath, abdominal distension, and lymphadenopathy for few years. Finally, she was diagnosed with paraprotein-negative POEMS syndro...
Paraprotein-negative POEMS syndrome....
Lenalidomide-based regimen and some supportive therapy....
All symptoms were relieved after 1 year of treatment....
Physicians should pay more attention to the POEMS syndrome, especially the POEMS syndrome variants, which are absence of paraprotein; probably, these variants are just "on the way" to classic POEMS sy...
Paraprotein gap is sometimes used as a screening tool in some autoimmune diseases, cancers, and screening for latent infections. The increase in the paraprotein gap in these diseases was hypothesized ...
Monoclonal gammopathy is a heterogeneous group of disorders due to the clonal proliferation of immunoglobulin-producing plasma cells or B lymphocytes. Patients develop kidney disease not only due to m...
A retrospective observational study was performed at three tertiary care centers in Southern India. Kidney biopsies conducted in these three centers were reviewed from June 1, 2020 to November 30, 202...
A total of 122 patients were included in the study with an incidence of 2.4%. The mean age was 52.27 ± 13.27 years, and majority (63.1%) were males. AL amyloidosis was most common in the monoclonal ga...
Paraproteinemia is associated with a myriad of kidney lesions. MGRS and MM are usually present in the 6...